Respirerx Pharmaceuticals Inc.
RSPI
Revenue
12.38k
▼-62.15k▼-83.39%
3 Months ChangeAssets
108.66k
▼-32.61k▼-23.08%
3 Months ChangeLiabilities
12.41M
▲121.49k▲0.9890%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-06
Form 8-K
ID: 0001493152-24-035221
2024-08-02
Form 8-K
ID: 0001493152-24-029979
2024-07-08
Form 8-K
ID: 0001493152-24-026467
2024-05-29
Form 8-K
ID: 0001493152-24-021733
2024-04-16
Form 8-K
ID: 0001493152-24-014816
2024-02-02
Form 8-K
ID: 0001493152-24-004660
2024-01-22
Form 8-K
ID: 0001493152-24-003131
2023-12-11
Form 8-K
ID: 0001493152-23-044326
2023-11-17
Form 10-Q
ID: 0001493152-23-041875
2023-10-12
Form 8-K
ID: 0001493152-23-036993